Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Bleeding Outcomes in Participants with Factor VIII Activity <5 IU/DL Post-Gene Transfer in GENEr8-1

Johnny Mahlangu, Margareth Castro Ozelo, Chee Wee Tan, Adam Giermasz, Jiaan-Der Wang, Dane Osmond, Hua Yu, Tara M. Robinson

Blood (2023) 142 (Supplement 1): 2250.

https://doi.org/10.1182/blood-2023-180083

Published: 2023

Journal Articles

Relationship between Endogenous, Transgene FVIII Expression and Bleeding Events Following Valoctocogene Roxaparvovec Gene Transfer for Severe Hemophilia A: A Post-Hoc Analysis of the GENEr8-1 Phase 3 Trial

Blood (2021) 138 (Supplement 1): 3972.

https://doi.org/10.1182/blood-2021-144508

Published: 2021

Journal Articles

Cigarette Smoking Exacerbates Flu-Induced Thrombo-Inflammation

Tomasz W. Kaminski, Tomasz Brzoska, Ravi Vats, Egemen Tutuncuoglu, Kara Nickolich, Keven M. Robinson, Toru Nyunoya, Prithu Sundd

Blood (2021) 138 (Supplement 1): 991.

https://doi.org/10.1182/blood-2021-153697

Published: 2021

Journal Articles

Health-Related Quality of Life Following Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A in the Phase 3 Trial GENEr8-1

Blood (2021) 138 (Supplement 1): 4916.

https://doi.org/10.1182/blood-2021-146021

Published: 2021

Journal Articles

Central Memory T-Cell Differentiation Correlates with Depth of Response in Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab in Combination with Carfilzomib, Lenalidomide and Dexamethasone (Elo-KRd)

David M Foureau, Manisha Bhutani, Fei Guo, Kateryna Fesenkova, Shebli Atrash, Reed Friend, Barry Paul, Myra M Robinson, James T Symanowski, Lawrence J Druhan, Mauricio Pineda-Roman, Peter M. Voorhees, Saad Z. Usmani

Blood (2021) 138 (Supplement 1): 1585.

https://doi.org/10.1182/blood-2021-152505

Published: 2021

Journal Articles

Influence of Bone Marrow Stromal and Leukemic Cells on Cytarabine Chemo-Toxicity in Acute Myeloid Leukemia (AML)

Liana E Gynn, BSc, Elizabeth Anderson, PhD, Gareth M Robinson, PhD, Sarah Anne Wexler, MBBS, MRCP, FRCPath, Gillian Upstill-Goddard, Christine Cox, Rhys Gareth Morgan, PhD, Jennifer E May, PhD BSc

Blood (2019) 134 (Supplement_1): 2492.

https://doi.org/10.1182/blood-2019-122891

Published: 2019

Journal Articles

Standard Definitions of Pneumococcal Immunity May Not Accurately Predict Protection in Adults with Sickle Cell Disease

Tara M. Robinson, MD PhD, Sophie M. Lanzkron, MD

Blood (2019) 134 (Supplement_1): 1014.

https://doi.org/10.1182/blood-2019-126056

Published: 2019

Journal Articles

Impact of Body Mass Index (BMI) on the Incidence of Bortezomib -Induced Peripheral Neuropathy (BIPN) in Patients with Newly Diagnosed Multiple Myeloma (MM)

Ala'a Muslimani, MD, Donald C Moore, PharmD, BCPS, BCOP, DPLA, Tanner Ringley, PharmD, BCOP, Myra M Robinson, MSPH

Blood (2018) 132 (Supplement 1): 2002.

https://doi.org/10.1182/blood-2018-99-110255

Published: 2018

Journal Articles

Risk Factors for Thromboembolism (TE) in Multiple Myeloma (MM) Patients (pts) Treated with Immunomodulatory Agents (IMiDs) Plus Dexamethasone (dex)

Jai N Patel, PharmD, BCOP, Megan Helena Jagosky, MD, Myra M Robinson, MSPH, Daniel Slaughter, Justin Arnall, PharmD, CPP, BCOP, Ashley Matusz-Fisher, MD, Manisha Bhutani, MD, Peter M. Voorhees, MD, Saad Z. Usmani, MD

Blood (2018) 132 (Supplement 1): 4814.

https://doi.org/10.1182/blood-2018-99-118283

Published: 2018

Journal Articles

Prognostic Significance of Tracking Dynamic Changes in Positron Emission Tomography (PET) Scan Pre and Post Autologous Stem Cell Transplant (ASCT)

Shebli Atrash, Myra M Robinson, MSPH, Manisha Bhutani, MD, Daniel Slaughter, Issam S. Hamadeh, PharmD, Peter M. Voorhees, MD, Jill Eddy, Lauren Minard, Reed Freind, Jordan Robinson, NDaiye AMI, Chelsea Sprouse, James Symanowski, PhD, Maham Khan, Belinda Rene Avalos, MD, Rajesh Banderudrappagari, Justin Arnall, PharmD, CPP, BCOP, Edward A. Copelan, MD, Saad Z. Usmani, MD

Blood (2018) 132 (Supplement 1): 5582.

https://doi.org/10.1182/blood-2018-99-118099

Published: 2018

Journal Articles

Prognostic Significance of Ki67 Expression By Immunohistochemistry (IHC) on Bone Marrow Biopsy in Newly Diagnosed Multiple Myeloma

Myra M Robinson, MSPH, Shebli Atrash, Taylor Brown, BS, MS, Jared G Block, MD, Edward H Lipford, MD, Elton T Smith, MD, Reed Friend, MD, Amanda Aneralla, Alankrita Taneja, MD, Qing Zhang, PhD, David M Foureau, PhD, Chelsea Sprouse, Ami Ndiaye, James T Symanowski, PhD, Belinda Rene Avalos, MD, Edward A Copelan, MD, Peter M. Voorhees, MD, Saad Z Usmani, MD, Manisha Bhutani, MD

Blood (2017) 130 (Supplement 1): 4348.

https://doi.org/10.1182/blood.V130.Suppl_1.4348.4348

Published: 2017

Journal Articles

Effect of Immunomodulatory Drugs (IMiDs) on Immune Effectors after Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma

David M Foureau, PhD, Manisha Bhutani, MD, Qing Zhang, PhD, Myra M Robinson, MSPH, Adina Wynn, Nury M Steuerwald, PhD, Lawrence J Druhan, PhD, Fei Guo, PhD, Katherine Rigby, Mitchell Turner, Reed Friend, MD, Shebli Atrash, Chelsea Sprouse, Ami Ndiaye, James T Symanowski, PhD, Belinda Rene Avalos, MD, Edward A Copelan, MD, Peter M. Voorhees, MD, Saad Z Usmani, MD

Blood (2017) 130 (Supplement 1): 1817.

https://doi.org/10.1182/blood.V130.Suppl_1.1817.1817

Published: 2017

Journal Articles

Validation of Dynamic Biomarker-Based Risk Progression Model for Smoldering Multiple Myeloma

Shebli Atrash, Myra M Robinson, MSPH, Amanda Aneralla, Taylor Brown, BS, MS, Reed Friend, MD, Chelsea Sprouse, Ami Ndiaye, Qing Zhang, PhD, Edward H Lipford, MD, Jared G Block, MD, Elton T Smith, MD, James T Symanowski, PhD, Belinda Rene Avalos, MD, Edward A Copelan, MD, Peter M. Voorhees, MD, Saad Z Usmani, MD, Manisha Bhutani, MD

Blood (2017) 130 (Supplement 1): 1779.

https://doi.org/10.1182/blood.V130.Suppl_1.1779.1779

Published: 2017

Journal Articles

Selecting between HLA-Matched Siblings and HLA- Haploidentical Related Donors for Acute Leukemia in the Era of Post-Transplant Cyclophosphamide: The Center for International Blood and Marrow Transplant Registry and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant

Blood (2017) 130 (Supplement 1): 851.

https://doi.org/10.1182/blood.V130.Suppl_1.851.851

Published: 2017

Journal Articles

Frontline Azacitidine As a Bridge to Allogeneic Transplantation in Acute Myeloid Leukemia

Michael Richard Grunwald, MD, Michael Keith Allister Zimmerman, MS, Danielle Boselli, MS, Lauren M. Bohannon, Myra M Robinson, MSPH, Daniel T. Peters, Jing Ai, MD PhD, Thomas G. Knight, MD, Jigar Trivedi, MSc, PharmD, Dragos Plesca, PharmD, James T Symanowski, PhD, Edward A Copelan, MD, Jonathan M. Gerber, MD

Blood (2017) 130 (Supplement 1): 3864.

https://doi.org/10.1182/blood.V130.Suppl_1.3864.3864

Published: 2017

Journal Articles

Peripheral Cellular Immunome Reveals Heterogeneity Spanning Myeloma Spectrum Diseases

Manisha Bhutani, MD, David M Foureau, PhD, Qing Zhang, PhD, Myra M Robinson, MSPH, Adina Wynn, Nury M Steuerwald, PhD, Lawrence J Druhan, PhD, Fei Guo, PhD, Katherine Rigby, Mitchell Turner, Reed Friend, MD, Shebli Atrash, Ami Ndiaye, Chelsea Sprouse, James T Symanowski, PhD, Belinda Rene Avalos, MD, Edward A Copelan, MD, Peter M. Voorhees, MD, Saad Z Usmani, MD

Blood (2017) 130 (Supplement 1): 3054.

https://doi.org/10.1182/blood.V130.Suppl_1.3054.3054

Published: 2017

Journal Articles

Immunological Correlates of Treatment with the CTLA-4 Inhibitor Ipilimumab in Patients with Refractory Myelodysplastic Syndromes (MDS)

Blood (2017) 130 (Supplement 1): 1699.

https://doi.org/10.1182/blood.V130.Suppl_1.1699.1699

Published: 2017

Journal Articles

Outcomes of Patients with Newly Diagnosed Aggressive B Cell Lymphoma Presenting with Hepatic and/ or Renal Dysfunction

Nilanjan Ghosh, MD PhD, Jigar Trivedi, MSc, PharmD, Srinivasa Reddy Sanikommu, MD, Myra M Robinson, MSPH, Ryan Jacobs, MD, Steven I Park, MD, Danyu Sun, MD PhD, James T Symanowski, PhD, Taylor Brown, BS, MS, Belinda Rene Avalos, MD, Edward A Copelan, MD

Blood (2017) 130 (Supplement 1): 5225.

https://doi.org/10.1182/blood.V130.Suppl_1.5225.5225

Published: 2017

Journal Articles

Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production

Blood (2017) 129 (18): 2570–2580.

https://doi.org/10.1182/blood-2017-01-758854

Published: 2017

Includes: Supplemental data

Journal Articles

Pirfenidone Reverses Murine Chronic Graft Versus Host Disease

Jing Du, Ryan P Flynn, PhD, Katelyn Paz, Ante Vulic, MD, Tara M. Robinson, MD PhD, Katie E Lineburg, BSc, Kelli P A Macdonald, PhD, Geoffrey R Hill, Jonathan S Serody, MD, Ivan Maillard, MD PhD, Angela Panoskaltsis-Mortari, PhD, Timothy Schacker, MD, Leo Luznik, MD, Bruce R. Blazar, MD

Blood (2016) 128 (22): 1158.

https://doi.org/10.1182/blood.V128.22.1158.1158

Published: 2016

NARROW

Bleeding Outcomes in Participants with Factor VIII Activity <5 IU/DL Post-Gene Transfer in GENEr8-1

Relationship between Endogenous, Transgene FVIII Expression and Bleeding Events Following Valoctocogene Roxaparvovec Gene Transfer for Severe Hemophilia A: A Post-Hoc Analysis of the GENEr8-1 Phase 3 Trial

Cigarette Smoking Exacerbates Flu-Induced Thrombo-Inflammation

Health-Related Quality of Life Following Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A in the Phase 3 Trial GENEr8-1

Central Memory T-Cell Differentiation Correlates with Depth of Response in Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab in Combination with Carfilzomib, Lenalidomide and Dexamethasone (Elo-KRd)

Influence of Bone Marrow Stromal and Leukemic Cells on Cytarabine Chemo-Toxicity in Acute Myeloid Leukemia (AML)

Standard Definitions of Pneumococcal Immunity May Not Accurately Predict Protection in Adults with Sickle Cell Disease

Impact of Body Mass Index (BMI) on the Incidence of Bortezomib -Induced Peripheral Neuropathy (BIPN) in Patients with Newly Diagnosed Multiple Myeloma (MM)

Risk Factors for Thromboembolism (TE) in Multiple Myeloma (MM) Patients (pts) Treated with Immunomodulatory Agents (IMiDs) Plus Dexamethasone (dex)

Prognostic Significance of Tracking Dynamic Changes in Positron Emission Tomography (PET) Scan Pre and Post Autologous Stem Cell Transplant (ASCT)

Prognostic Significance of Ki67 Expression By Immunohistochemistry (IHC) on Bone Marrow Biopsy in Newly Diagnosed Multiple Myeloma

Effect of Immunomodulatory Drugs (IMiDs) on Immune Effectors after Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma

Validation of Dynamic Biomarker-Based Risk Progression Model for Smoldering Multiple Myeloma

Frontline Azacitidine As a Bridge to Allogeneic Transplantation in Acute Myeloid Leukemia

Peripheral Cellular Immunome Reveals Heterogeneity Spanning Myeloma Spectrum Diseases

Immunological Correlates of Treatment with the CTLA-4 Inhibitor Ipilimumab in Patients with Refractory Myelodysplastic Syndromes (MDS)

Outcomes of Patients with Newly Diagnosed Aggressive B Cell Lymphoma Presenting with Hepatic and/ or Renal Dysfunction

Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production

Pirfenidone Reverses Murine Chronic Graft Versus Host Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only